Response from the owner: Hey, Madison
The timing of GLP-1 administration may influence how patients experience and tolerate side effects , though there is no conclusive evidence establishing that night-time dosing categorically reduces or increases adverse reactions
Fasting glucose measures the sugar in your blood when you have not eaten anything for at least 8 hours
Makhijani K, Kumbhare LB, Nayak M, Kunwar A, Singh BG
Cardiovascular Outcomes : Patients with type 2 diabetes and heart disease had a 20-30% reduction in major cardiovascular events when treated with OZEMPIC
Lillys oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine